MMJ PhytoTech Ltd (ASX:MMJ) today confirms that it has signed a definitive agreement with Canadian-based Harvest One Capital Corp. (CVE:WON). The definitive agreement outlines the sale of 100% of issued and outstanding shares of United Greeneries Holdings Ltd and Satipharm AG to Harvest One.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the company's AGM Presentation with the topic "Developing a World-Class Pure Play Cannabis Company".
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its Canadian subsidiary, United Greeneries Ltd, has received an Import Permit from Health Canada and the Canadian Food Inspection Agency, allowing for the importation of 1kg of cannabis seeds. Importantly, this will enable UG to commence cultivation activities at the Duncan Facility in December.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Canadian-based Mackie Research Capital Corporation has been appointed as lead manager for the equity financing component of the Company's proposed TSX-V listing.
MMJ PhytoTech Limited (ASX:MMJ) wishes to advise that it is fully supportive of recent amendments to Australian Commonwealth legislation, legalising cannabis-based products for medicinal or research purposes as controlled drugs.
MMJ PhytoTech Ltd (ASX:MMJ) advises that it has executed a binding Term Sheet with Canadian-based Harvest One Capital Corp. for the sale to Harvest One of 100% of the issued shares of United Greeneries Holdings Ltd and Satipharm AG respectively.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2016.
